Suchergebnisse - "Nirula, Ajay"

PubPharm (23)

1

A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis

enthalten in: The New England journal of medicine | 2023

von Tuttle, J. | Drescher, E. | Simón-Campos, J. | +7

CommentIn: N Engl J Med. 2023 Jul 27;389(4):378-379. - PMID 37494492

2

Emergence of SARS-CoV-2 escape mutations during Bamlanivimab therapy in a phase II randomized clinical trial

enthalten in: Nature microbiology | 2022

von Choudhary, M. | Chew, K. | Deo, R. | +56

3

A Randomized, Placebo-Controlled Clinical Trial of Bamlanivimab and Etesevimab Together in High-Risk Ambulatory Patients With COVID-19 and Validation of the Prognostic Value of Persistently High Viral Load

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2022

von Dougan, M. | Azizad, M. | Mocherla, B. | +31

4

Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

enthalten in: Nature communications | 2022

von Chew, K. | Moser, C. | Daar, E. | +23

ErratumIn: Nat Commun. 2023 Jan 19;14(1):333. - PMID 36658128

5

The anti-SARS-CoV-2 monoclonal antibody bamlanivimab minimally affects the endogenous immune response to COVID-19 vaccination

enthalten in: Science translational medicine | 2022

von Benschop, R. | Tuttle, J. | Zhang, L. | +13

6

Monoclonal antibody treatment drives rapid culture conversion in SARS-CoV-2 infection

enthalten in: Cell reports. Medicine | 2022

von Boucau, J. | Chew, K. | Choudhary, M. | +23

UpdateOf: medRxiv. 2021 Dec 30;:. - PMID 35018382

7

A Quantitative Modeling and Simulation Framework to Support Candidate and Dose Selection of Anti-SARS-CoV-2 Monoclonal Antibodies to Advance Bamlanivimab Into a First-in-Human Clinical Trial

enthalten in: Clinical pharmacology and therapeutics | 2022

von Chigutsa, E. | Jordie, E. | Riggs, M. | +4

8

First-in-Human Study of Bamlanivimab in a Randomized Trial of Hospitalized Patients With COVID-19

enthalten in: Clinical pharmacology and therapeutics | 2021

von Chen, P. | Datta, G. | Grace Li, Y. | +16

9

Bamlanivimab plus Etesevimab in Mild or Moderate Covid-19

enthalten in: The New England journal of medicine | 2021

von Dougan, M. | Nirula, A. | Azizad, M. | +131

10

Effect of Bamlanivimab vs Placebo on Incidence of COVID-19 Among Residents and Staff of Skilled Nursing and Assisted Living Facilities : A Randomized Clinical Trial

enthalten in: JAMA | 2021

von Cohen, M. | Nirula, A. | Mulligan, M. | +52

CommentIn: JAMA. 2021 Jul 6;326(1):31-32. - PMID 34081075